Microbiome-supporting raw materials and bio-diagnostic systems for American clean beauty brands
The shift from aggressive treatments to barrier restoration in North America
The cosmetic market in the United States is witnessing a paradigm shift. For decades, the dominant skincare narrative focused on aggressive exfoliation, high-percentage acid treatments, and sterile dermis profiles. However, consumer awareness has evolved. Today, dermatological science points directly to the skin microbiome—a complex, delicate ecosystem of billions of microorganisms, fungi, and bacteria living on the stratum corneum—as the true gatekeeper of skin barrier function, immunity, and overall skin health.
In response, high-growth American brands are phasing out traditional soap-based surfactants and harsh preservatives. Instead, they are prioritizing microbiome-friendly formulations. This seismic market transition has created an unprecedented demand for agile, high-tech OEM/ODM manufacturing partners capable of balancing product preservation with microbial viability. To serve the US market effectively, factories must operate under strict regulatory criteria while utilizing bio-derived, highly stable raw materials that do not disrupt the skin's natural pH and commensal bacterial populations (such as Staphylococcus epidermidis).
Overcoming formulation stability, regulatory friction, and claims validation
Purchasing directors, cosmetic scientists, and brand founders in the United States face significant hurdles when sourcing microbiome products globally. The three main pain points include:
Traditional broad-spectrum preservative systems are designed to eliminate microbes inside the bottle, but they often disrupt the skin microbiome upon application. Finding the optimal formulation that maintains product safety (USP <51> Challenge Testing) without killing beneficial skin bacteria is a complex balancing act.
Probiotic ingredients are highly sensitive to thermal fluctuations, UV exposure, and mechanical stress during transoceanic shipping. Uncontrolled shipping environments can degrade active strains, reducing their effectiveness and causing inconsistencies between factory batches and the products delivered to US warehouses.
With the introduction of the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), the FDA has tightened rules on facility registration, product listing, safety substantiation, and adverse event reporting. Global factories must provide transparent, trace-validated documents to survive rigorous customs audits.
Premium OEM, ODM & OBM Cosmetics Manufacturer · Guangdong, China
Guangdong Miura Beauty Co. Ltd. is a leading, full-service cosmetics manufacturer specializing in clinical-grade OEM, ODM, and OBM solutions for the global skincare industry, with a strong focus on the United States market. Operating a modern 25,000-square-meter manufacturing facility, we integrate advanced cosmetic chemistry, automation, and end-to-end brand support services to bring cutting-edge formulations to market efficiently.
Equipped with 32 fully automated production lines, our facility offers rapid, high-volume production while maintaining strict quality control. Our R&D center, led by experienced cosmetic chemists, specializes in advanced delivery systems like nano-emulsions, lipid encapsulation, botanical bioactives, and clean beauty formulas designed to protect the skin barrier and support a healthy microbiome.
Develops customized skincare solutions with optimized texture, stability, and performance tailored to global market trends and scientific advancements.
Ensures every production batch meets strict international standards through comprehensive process testing and compliance controls (GMPC, ISO 22716, FDA).
Creates complete brand packaging solutions, combining high aesthetics, premium functionality, and targeted market positioning.
Provides end-to-end support for global clients, ensuring clear communication, rapid product development, and reliable delivery.
Transparent visual overview of our industrial machinery, raw processing, and assembly lines
The scientific approach to stable microbiome-friendly cosmetic manufacturing
Developing effective microbiome-friendly skincare requires a detailed understanding of the scientific pathways that support skin ecosystem health. Our laboratory focuses on three primary functional categories:
Seamless customs clearing, FDA documentation, and batch consistency
To help US brands minimize operational risks, our manufacturing process aligns with current US regulatory frameworks:
Clinical-grade formulas ready for custom branding and private label scaling
Direct answers from our senior R&D and regulatory compliance division
Miura Beauty
